In the current study, using a late-onset AD mouse model, hAbKI mice [42], we tested urolithin A and in the combination of both urolithin A+ green tea extract EGCG against human Abeta peptide-induced mitochondrial and synaptic, dendritic and inflammatory toxicities in mice. The gene discussed is APP; the disease is Alzheimer disease.